Medicare Enrolled
Dr. Juan Ros-Escalante, M.D.
Neurology · Lake Mary, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ros-Escalante from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ros-Escalante?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ros-Escalante
Dr. Juan Ros-Escalante is a neurology specialist in Lake Mary, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ros-Escalante performed 1,013 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ros-Escalante received a total of $5,018 from 40 pharmaceutical and/or device companies across 252 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ros-Escalante is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 31% volume in FL
$5,018 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 109269 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,013
Medicare services
Top 31% in FL for neurology
Not available
Unique patients (not deduplicated)
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
300 | $95 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
144 | $91 | $220 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
134 | $135 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $123 | $350 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
48 | $140 | $600 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $70 | $250 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
47 | $51 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $61 | $190 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
41 | $98 | $425 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
36 | $86 | $175 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
32 | $123 | $375 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
26 | $158 | $475 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $122 | $350 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
13 | $334 | $700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,018
Total received (2018-2024)
Avg $717/year across 7 years
Top 38% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
252
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,100
2023
$1,302
2022
$1,075
2021
$619
2020
$73
2019
$456
2018
$395
Payments by company (2024)
ABBVIE INC.
$260
PFIZER INC.
$154
Otsuka America Pharmaceutical, Inc.
$93
Takeda Pharmaceuticals U.S.A., Inc.
$91
Biogen, Inc.
$83
Lilly USA, LLC
$81
Eisai Inc.
$72
ARGENX US, INC.
$47
UCB, Inc.
$38
Microtransponder, Inc.
$37
Teva Pharmaceuticals USA, Inc.
$36
CSL Behring
$30
Novartis Pharmaceuticals Corporation
$22
Genentech USA, Inc.
$21
Alexion Pharmaceuticals, Inc.
$20
Lundbeck LLC
$13
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$509
Takeda Pharmaceuticals U.S.A., Inc.
$343
AbbVie Inc.
$339
ARGENX US, INC.
$308
PFIZER INC.
$275
EMD Serono, Inc.
$245
Biogen, Inc.
$240
Novartis Pharmaceuticals Corporation
$237
GENZYME CORPORATION
$214
Lilly USA, LLC
$201
Janssen Pharmaceuticals, Inc
$177
Alnylam Pharmaceuticals Inc.
$152
Genentech USA, Inc.
$149
CSL Behring
$148
Alexion Pharmaceuticals, Inc.
$146
Grifols USA, LLC
$140
Eisai Inc.
$134
Teva Pharmaceuticals USA, Inc.
$117
GE HealthCare
$111
Otsuka America Pharmaceutical, Inc.
$93
Allergan Inc.
$89
Biohaven Pharmaceuticals, Inc.
$74
UCB, Inc.
$57
Amgen Inc.
$54
CATALYST PHARMACEUTICALS, INC.
$49
PORTOLA PHARMACEUTICALS, INC.
$42
Strongbridge US INC.
$39
Microtransponder, Inc.
$37
Supernus Pharmaceuticals, Inc.
$37
Lundbeck LLC
$36
ACADIA Pharmaceuticals Inc
$36
Xeris Pharmaceuticals, Inc.
$31
GE HEALTHCARE
$31
Impax Laboratories, Inc.
$29
Ethicon US, LLC
$20
Acorda Therapeutics, Inc
$19
Banner Life Sciences, LLC
$18
Ultragenyx Pharmaceutical Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$15
Allergan, Inc.
$11
Top 3 companies account for 23.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · AUBAGIO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · COPAXONE · EMGALITY · FIRDAPSE · GAMMAGARD · GAMMAGARD LIQUID · GILENYA · Gamunex-C · HYQVIA · Hizentra · INBRIJA · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LINX Reflux Management System · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NUPLAZID · NURTEC ODT · OCREVUS · ONPATTRO · Ocrevus · PANZYGA · PAXLOVID · Ponvory · QULIPTA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · Soliris · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VYEPTI · VYVGART · VYVGART HYTRULO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
80
County median income
$83,030
Nearest hospital to ZIP centroid (approximate)
CENTRAL FLORIDA LAKE MONROE HOSPITAL
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ros-Escalante is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ros-Escalante experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ros-Escalante performed 300 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ros-Escalante receive payments from pharmaceutical companies?
Yes. Dr. Ros-Escalante received a total of $5,018 from 40 companies across 252 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ros-Escalante's costs compare to other neurologists in Lake Mary?
Dr. Ros-Escalante's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ros-Escalante) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Lake Mary
Browse neurologists in Lake Mary ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology